Human guanylate binding proteins: nanomachines orchestrating host defense

Area of Science:

• Immunology
• Cell Biology
• Microbiology

Background:

• Intracellular pathogens pose a significant threat, necessitating robust host cell defenses.
• Cell-autonomous immunity, executed by host cells, is crucial for combating intracellular infections.
• Dynamin-related guanylate binding proteins (GBPs) are central to human cell-autonomous immunity.

Purpose of the Study:

• To elucidate the molecular mechanisms of GBP-mediated cell-autonomous immunity.
• To provide a framework for understanding GBP functions in host defense against pathogens.
• To present testable hypotheses for future research on GBPs in human disease.

Main Methods:

• Focus on cell biological and biochemical studies of prenylated GBPs (GBP1, GBP2, GBP5).
• Characterization of GBP1 as a pattern recognition receptor for bacterial lipopolysaccharide (LPS).
• Investigation of GBP1's role in inflammasome activation and GBP2/GBP5's inhibition of viral glycoprotein processing.

Main Results:

• GBP1 aggregates bacterial LPS, disrupting outer membranes and activating inflammasomes.
• GBP2 and GBP5 inhibit viral envelope glycoprotein processing by suppressing furin.
• Established molecular frameworks for GBP-mediated immunity against diverse pathogens.

Conclusions:

• GBPs function as key nanomachines in cell-autonomous immunity.
• Understanding GBP mechanisms offers insights into antimicrobial and proinflammatory host defense.
• This knowledge guides future research into GBP roles in human infectious diseases.